Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nereus Pharmaceuticals, Inc.

http://www.nereuspharm.com/

Latest From Nereus Pharmaceuticals, Inc.

Asia Deal Watch: Cancer Collaborations, Licensings Lead Activity In Asia

Cancer deals involving Junshi/Wigen, Allist/Octimet, Yufan/Abound, Takeda/Presage, Daiichi Sankyo/AnHeart, LegoChem/Harbour Biomed, plus a stem cell partnership and a lysosomal storage disorder agreement.

Deals Business Strategies

China IPO Roundup: Strong Spring Financings For Pharma And Biotech

China’s healthcare sector was back to actively raising proceeds from the capital markets in March and April, which witnessed more than 20 IPOs in total, with a stream of other listings being planned.

China Financing

Start-Up Quarterly Statistics: Early Funding Declined, But Deal Dollars Flowed

A review of biopharma startup dealmaking and financing activity from January through March 2017, based on data from Strategic Transactions, showed a 19% decline in startup financing compared with the fourth quarter of 2016, but big pharmas provided capital in the form of alliance fees.

StartUps and SMEs Financing

Array hires Howard Holden as VP

Array BioPharma, a company focused on discovering and developing targeted small-molecule drugs to treat cancer and inflammatory diseases has appointed Dr Howard Holden vice-president of regulatory affairs and quality assurance. Dr Holden served as senior vice-president of regulatory affairs and compliance at Nereus Pharmaceuticals from 2005-2012.

Cancer
See All

Company Information

UsernamePublicRestriction

Register